Shaun Bagai, Chief Executive Officer of RenovoRx, commented, "2025 marked a key year as it was our first full year of RenovoCath commercialization, generating over $1 million in revenue and reflecting ...
It involves substances “not for human use.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results